NewsRoom Articles - Page 105 of 115

TuesdayMar 06, 2018 2:39 pm

Cronos Group Inc. (NASDAQ: CRON) (TSX.V: MJN) Becomes First Canadian Cannabis Producer to be Traded on a Major US Exchange

Analysts call the listing a milestone for both Cronos Group and the entire cannabis industry Michael Gorenstein, CEO of Cronos Group, said that the company is the only ‘pure play’ marijuana company to be traded on a U.S. exchange Company has holdings or is involved in joint ventures in Canada, Germany, Israel and Australia Cronos Group Inc. (NASDAQ: CRON) (TSX.V: MJN), a Toronto-based medical marijuana company, recently began trading on the Nasdaq, uplisting from the Nasdaq International Designation program as an OTC stock to the Nasdaq Global Market and becoming the first Canadian cannabis producer stock to be listed on…

FridayMar 02, 2018 12:10 pm

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Opens the Door for Canadian Entrepreneurs with Dispensary Rollout Strategy

Recreational marijuana set to be legalized in Canada in July 2018 Choom™ is developing unique lifestyle brand and national retail footprint in new $8.7 billion-plus market Retail rollout strategy provides entrepreneurs opportunity to profit from coming bonanza Entrepreneurs and businesspeople across Canada now have the opportunity to participate in the country’s lucrative new recreational marijuana market. Estimated to exceed $8.7 billion annually, recreational marijuana is set to be legalized in July of this year, and savvy business folks are looking for a piece of the cannabis pie. This is little wonder, since legal recreational marijuana dispensaries are expected generate more…

ThursdayMar 01, 2018 2:31 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Seven-Year Licensing Agreement with Cannfections Group, Inc.

Cannabis-infused chocolates and candies, such as gummies, will be manufactured using LXRP’s next-generation, patented technology to be sold in Canada and internationally, where permitted LXRP’s goal is to partner with manufacturers who provide best-in-class products to existing large consumer groups Licensing DehydraTECH™ is key to LXRP’s generation of revenue; LXRP aims to license its IP in all countries where its technology is patented or patent pending Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) continues to generate revenue from licensing its proprietary and patented technology DehydraTECH™, which is already patented in the U.S. and Australia. The company also has multiple patents…

ThursdayMar 01, 2018 12:21 pm

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. Near Completion of cannaBLOX White Paper

Companies in partnership to create cannaBLOX, a blockchain-based software smart contract platform for the legalized cannabis industry cannaBLOX blockchain software is a supply chain management platform designed to ease logistical bottlenecks, minimize fraud, assist in taxation and ensure regulatory compliance LIBFF and BLLXF have completed preliminary input and analysis in their joint phase one development of cannaBLOX Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) have announced progress on their joint development of phase one of cannaBLOX, the blockchain-based smart contract platform for the legalized cannabis industry (http://cnw.fm/u9FqN). Blox Labs…

WednesdayFeb 28, 2018 12:16 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is Uniquely Positioned within the Cannabis Industry

Cannabis deals in Canada cross the billion-dollar mark DehydraTech™ offers new and innovative methods of oral delivery Committed to high quality products using revolutionary technology The only company in the world with patents for this innovative edible technology Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) expects to benefit significantly as cannabis deals in Canada cross the billion-dollar mark in anticipation of the legalization of recreational cannabis, which is only months away (http://cnw.fm/IY0qK). Its newly developed oral digestion technology, DehydraTECH™, is a complementary layer that works with other R&D being done on cannaboids. LXRP has been awarded a patent in the…

MondayFeb 26, 2018 3:41 pm

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Evokes Good Times Vibe in Build up to Canadian Marijuana Legalization

Canada expects to make recreational marijuana use legal nationwide later this year Legalized revenues have forecast potential to reach up to $8.7 billion, with more than $20 billion for ancillary services CHOOF invites ‘good people’ to open franchise retail dispensaries While winter days in frigid northern climates mean snow and cold winds, a company in Canada’s British Columbia is embracing the timeless warmth of Hawaii’s laid-back lifestyle. Choom™ Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is building a friendly entry into the country’s growing legalized cannabis industry as it awaits final stage approval of its Access to Cannabis for Medical Purposes…

MondayFeb 26, 2018 3:05 pm

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) Pursuing Opportunities in America’s ‘New Billion-Dollar Crop’

Relaxed U.S. restrictions on hemp production increasingly likely Hemp extraction legislation expected to occur in Canada in mid-to-late 2018 Hemp used in dozens of applications across the industrial spectrum “Soil-to-Shelf” strategy for development of hemp in Canada and the United States If you lived in Jamestown in the late eighteenth century, the first permanent English settlement in what became the United States, and you did not grow cannabis, you would most likely earn the contempt of fellow citizens. You could also end up in jail; refusing to grow cannabis sativa, known as Indian hemp, was actually against the law in…

MondayFeb 26, 2018 2:34 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Advances CBD Therapy Delivery Options

Forecasts envision medical cannabis market reaching $55.8 billion by 2025 PVOTF filing patents for smoked, transdermal and mucosal delivery of therapeutics Global partnerships and acquisitions open windows of opportunity for company With its recently announced plan to acquire Agro-Biotech, a Québec-based ACMPR Canadian licensed cannabis producer (http://cnw.fm/WPwl2), Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) has raised the bar in the race to capture part of the booming medical cannabis market, which is expected to reach over $55 billion by 2025. Agro-Biotech, which operates a fully-licensed indoor hydroponic cannabis production facility that’s able to turn out 10,000 kilograms per year, gives…

MondayFeb 26, 2018 1:02 pm

The Green Organic Dutchman is Farming One Million Square Feet of Organic Cannabis as Supply Shortfall Looms

Focused on medical market with organic marijuana Large scale production to reap benefits from economies of scale Partnerships with utilities to lower power costs As one of just two producers of organic cannabis and with a million square feet of low cost production planned, the Green Organic Dutchman Holdings Ltd. (“TGOD”) is set to capitalize on Canada’s looming supply shortfall. The company is growing its competitive advantage in a way that appears to run contrary to established dictum by focusing not just on differentiation but also on cost leadership. Typical generic strategies are either one or the other. This unique…

FridayFeb 23, 2018 12:15 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) “Seed to Derivatives” – Vertical Integration in Burgeoning Cannabis Market

Letter of Intent to acquire Agro-Biotech, to become vertically integrated from “seed to derivatives” Development and commercialization of therapeutic pharmaceuticals and nutraceuticals Patented formulation and delivery technologies Scientific studies have provided empirical credence to the medical efficacy of cannabinoids for multiple maladies. Globally, researchers and biopharmaceutical companies are now laser focused on cannabinoid-based therapeutics that may hold blockbuster medical potential, providing solutions to a range of unmet medical needs. However, current drug delivery techniques remain antiquated. There are inherent metabolic and bioavailability issues affecting the consistent, effective delivery of cannabinoids. It’s becoming clear that these new pharmaceutical therapeutics require revolutionary…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000